Intec Pharma Ltd Company Profile (NASDAQ:NTEC)

About Intec Pharma Ltd

Intec Pharma Ltd logoIntec Pharma Ltd is an Israel-based drug development company. It is a development stage biopharmaceutical company that develops formulations of drugs using its proprietary gastric retention technology, the Accordion Pill. The Accordion Pill, a novel gastro-retentive delivery system, improves the pharmacokinetics and pharmacodynamics of various drugs. The Company is focusing on the clinical development program for the Phase III clinical study of the Accordion Pill Carbidopa Levodopa (AP-CDLD), for the treatment of advanced stages Parkinson's disease patients. Its pipeline also comprises The Accordion Pill-Zaleplon, a drug for sleep onset, which is in Phase II clinical program. Furthermore under research is Accordion Pill-Undisclosed Drug for the prevention and treatment of small bowel non-steroidal anti-inflammatory drug (NSAID) induced ulcers.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: NTEC
  • CUSIP:
Key Metrics:
  • Previous Close: $5.80
  • 50 Day Moving Average: $6.00
  • 200 Day Moving Average: $4.66
  • 52-Week Range: $11,399,000.00 - $3.03
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -4.50
  • P/E Growth: 0.00
  • Market Cap: $66.11M
  • Outstanding Shares: 11,399,000
Additional Links:
Companies Related to Intec Pharma Ltd:

Analyst Ratings

Consensus Ratings for Intec Pharma Ltd (NASDAQ:NTEC) (?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $9.00 (55.17% upside)

Analysts' Ratings History for Intec Pharma Ltd (NASDAQ:NTEC)
Show:
DateFirmActionRatingPrice TargetDetails
4/5/2016Maxim GroupReiterated RatingBuy$9.00View Rating Details
12/16/2015Roth CapitalReiterated RatingBuyView Rating Details
(Data available from 9/25/2014 forward)

Earnings

Earnings History for Intec Pharma Ltd (NASDAQ:NTEC)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Intec Pharma Ltd (NASDAQ:NTEC)
Current Year EPS Consensus Estimate: $-1.14 EPS
Next Year EPS Consensus Estimate: $-1.29 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.34)($0.34)($0.34)
Q2 20161($0.34)($0.34)($0.34)
Q3 20161($0.34)($0.34)($0.34)
Q4 20161($0.35)($0.35)($0.35)
Q1 20171($0.35)($0.35)($0.35)
Q2 20171($0.35)($0.35)($0.35)
Q3 20171($0.31)($0.31)($0.31)
Q4 20171($0.31)($0.31)($0.31)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Intec Pharma Ltd (NASDAQ:NTEC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Intec Pharma Ltd (NASDAQ:NTEC)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Intec Pharma Ltd (NASDAQ:NTEC)
DateHeadline
4-traders.com logoIntec Pharma : NTEC) Gives Up 4.07% at Midday on September 22, Pressuring Health Care Stocks (NASDAQ:NTEC)
www.4-traders.com - September 23 at 6:00 PM
publicnow.com logoIntec Pharma Ltd. (NTEC) Gives Up 4.07% at Midday on September 22, Pressuring Health Care Stocks (NASDAQ:NTEC)
www.publicnow.com - September 23 at 6:00 PM
finance.yahoo.com logoIntec Pharma to Participate in Upcoming September Conferences (NASDAQ:NTEC)
finance.yahoo.com - September 7 at 6:38 PM
finance.yahoo.com logoIntec Pharma Granted European Patent for Accordion Pill™–Carbidopa / Levodopa (NASDAQ:NTEC)
finance.yahoo.com - September 7 at 10:03 AM
publicnow.com logoIntec Pharma Granted European Patent for Accordion Pill(TM)-Carbidopa / Levodopa (NASDAQ:NTEC)
www.publicnow.com - September 6 at 11:12 AM
rttnews.com logoIntec Pharma Posts Wider Loss In Q2 - Quick Facts (NASDAQ:NTEC)
www.rttnews.com - September 2 at 11:20 AM
4-traders.com logoIntec Pharma : net loss widens in Q2; shares up 7% premarket (NASDAQ:NTEC)
www.4-traders.com - September 2 at 11:20 AM
businesswire.com logoIntec Pharma Reports First Half 2016 Financial Results (NASDAQ:NTEC)
www.businesswire.com - September 2 at 11:20 AM
publicnow.com logoIntec Pharma net loss widens in Q2; shares up 7% premarket (NASDAQ:NTEC)
www.publicnow.com - September 1 at 9:39 AM
News IconIntec Pharma begins clinical development of Accordion Pill for cannabinoid therapies (NASDAQ:NTEC)
www.bioportfolio.com - August 7 at 10:41 AM
publicnow.com logoIntec Pharma to Pursue Development of Accordion Pill for Cannabinoid Therapies (NASDAQ:NTEC)
www.publicnow.com - August 4 at 9:41 AM
publicnow.com logoIntec Pharma Ltd. (NTEC) Charges Ahead 8.2%, Just After Opening Bell on August 1 to Bolster Health Care Stocks (NASDAQ:NTEC)
www.publicnow.com - August 2 at 11:23 AM
publicnow.com logoHealth Care Firm Intec Pharma Ltd. (NTEC) Advances 11.52% at Midday on August 1 (NASDAQ:NTEC)
www.publicnow.com - August 2 at 11:23 AM
News IconIndian student warns his countrymen over fraudulent paperwork (NASDAQ:NTEC)
www.tvnz.co.nz - July 2 at 9:18 AM
rttnews.com logoIntec Pharma Names Nir Sassi CFO, Effective Aug. 1, Succeeding Oren Mohar (NASDAQ:NTEC)
www.rttnews.com - June 3 at 9:23 AM
News IconIntec Pharma Announces Planned Management Changes (NASDAQ:NTEC)
www.kait8.com - June 3 at 9:23 AM
publicnow.com logoIntec Pharma Receives Approval for US$5.2 Million Grant (NASDAQ:NTEC)
www.publicnow.com - May 31 at 8:42 AM
nasdaq.com logoIntec Pharma Nominates John Kozarich As Chairman Of Board - Quick Facts (NASDAQ:NTEC)
www.nasdaq.com - May 16 at 1:09 PM
publicnow.com logoIntec Pharma to Nominate Dr. John W. Kozarich as Chairman of the Board of Directors (NASDAQ:NTEC)
www.publicnow.com - May 16 at 8:42 AM
publicnow.com logoIntec Pharma Appoints VP of Clinical and Regulatory Affairs (NASDAQ:NTEC)
www.publicnow.com - May 3 at 8:10 AM
publicnow.com logoIntec Pharma Enrolls First Patient in Pivotal Phase III Clinical Trial of AP-CDLD for Advanced Parkinson’s Disease Patients (NASDAQ:NTEC)
www.publicnow.com - April 11 at 4:07 AM
publicnow.com logoIntec Pharma Expands Intellectual Property for AP-CDLD with Patent in South Korea (NASDAQ:NTEC)
www.publicnow.com - April 6 at 8:10 AM
rttnews.com logoCYTR Awaits Data In June, GILD Gets FDA Nod, PGNX Will Have To Wait (NASDAQ:NTEC)
www.rttnews.com - April 5 at 11:54 AM
publicnow.com logoIntec Pharma Enrolls First Patient in Pivotal Phase III Clinical Trial of AP-CDLD for Advanced Parkinson's Disease Patients (NASDAQ:NTEC)
www.publicnow.com - April 4 at 8:07 AM
4-traders.com logoIntec Pharma : Mr. Zvika Joseph to Step Down as Chairman of the Board of Directors (NASDAQ:NTEC)
www.4-traders.com - March 19 at 11:19 AM
finance.yahoo.com logoINTEC PHARMA LTD. Financials (NASDAQ:NTEC)
finance.yahoo.com - March 17 at 1:04 PM
finance.yahoo.com logoMr. Zvika Joseph to Step Down as Chairman of the Board of Directors (NASDAQ:NTEC)
finance.yahoo.com - March 17 at 10:30 AM
finance.yahoo.com logoIntec Pharma Reports 2015 Fourth Quarter and Full-Year Financial Results (NASDAQ:NTEC)
finance.yahoo.com - March 14 at 7:45 AM
finance.yahoo.com logoIntec Pharma Ltd. Announces Availability of Its Annual Report on Form 20-F Through Its Website (NASDAQ:NTEC)
finance.yahoo.com - March 14 at 7:30 AM
finance.yahoo.com logoIntec Pharma Ltd.: Notice of Special General Meeting of Shareholders (NASDAQ:NTEC)
finance.yahoo.com - March 14 at 7:15 AM
fxpips.com logoActive Stocks Climbing Strong – PULM, HTGM, SHIP, NTEC, SYX, DWCH, BPI (NASDAQ:NTEC)
www.fxpips.com - March 10 at 11:22 AM
finance.yahoo.com logo8:11 am Intec Pharma completes Phase 1 clinical trial with third pipeline product (NASDAQ:NTEC)
finance.yahoo.com - March 10 at 8:11 AM
finance.yahoo.com logoIntec Pharma Completed a Phase I Clinical Trial With Its Third Pipeline Product (NASDAQ:NTEC)
finance.yahoo.com - March 10 at 8:00 AM
bloomberg.com logoCompany Overview of Intec Pharma Ltd. (NASDAQ:NTEC)
www.bloomberg.com - March 7 at 11:20 AM
finance.yahoo.com logoIntec Pharma Ltd. (NTEC) (NASDAQ:NTEC)
finance.yahoo.com - January 28 at 10:35 AM
finance.yahoo.com logoIntec Pharma to Present at Biotech Showcase 2016 (NASDAQ:NTEC)
finance.yahoo.com - January 5 at 7:00 AM
noodls.com logoIntec Pharma Further Expands Intellectual Property with a New Patent for the Accordion Pill Zaleplon in Europe (NASDAQ:NTEC)
www.noodls.com - December 16 at 10:59 AM
noodls.com logoIntec Pharma Receives an IRB Approval to initiate Phase III Clinical Trial of AP – CDLD for the Treatment of Parkinson’s Disease (NASDAQ:NTEC)
www.noodls.com - December 14 at 10:14 AM
finance.yahoo.com logoIntec Pharma Receives an IRB Approval to Initiate Phase III Clinical Trial of AP - CDLD for the Treatment of Parkinson's Disease (NASDAQ:NTEC)
finance.yahoo.com - December 14 at 8:09 AM
noodls.com logoEntering Phase I clinical trial with our third pipeline product (NASDAQ:NTEC)
www.noodls.com - December 9 at 7:08 AM
finance.yahoo.com logoIntec Pharma Enters Phase I Clinical Trial With Its Third Pipeline Product (NASDAQ:NTEC)
finance.yahoo.com - December 8 at 8:30 AM
finance.yahoo.com logoIntec Pharma Reports Results for the Third Quarter of 2015 (NASDAQ:NTEC)
finance.yahoo.com - November 5 at 4:30 PM
finance.yahoo.com logoIntec Pharma Expands Intellectual Property With a New Patent for the Accordion Pill in Europe (NASDAQ:NTEC)
finance.yahoo.com - October 22 at 8:30 AM
finance.yahoo.com logoIntec Pharma Announces Topline Results of a Food Effect, Pharmacokinetic Study of AP-CDLD 50/500mg for the Treatment of Parkinson's Disease Symptoms (NASDAQ:NTEC)
finance.yahoo.com - October 12 at 9:37 PM
finance.yahoo.com logoIntec Pharma Ltd. Announces Partial Exercise of Underwriters Option to Purchase Additional Ordinary Shares (NASDAQ:NTEC)
finance.yahoo.com - September 17 at 5:58 PM
noodls.com logoIntec Pharma Ltd. Announces Closing of U.S. Initial Public Offering (NASDAQ:NTEC)
www.noodls.com - August 14 at 10:51 AM
noodls.com logoIntec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering (NASDAQ:NTEC)
www.noodls.com - August 6 at 5:40 AM

Social

Intec Pharma Ltd (NASDAQ:NTEC) Chart for Sunday, September, 25, 2016


Last Updated on 9/25/2016 by MarketBeat.com Staff